尋找研究成果

搜尋結果

• 2017

  Angiotensin II receptor type 1 A1166C modifies the association between angiotensinogen M235T and chronic kidney disease

  Su, S. L., Chen, W. T., Hsiao, P. J., Lu, K. C., Lin, Y. F., Lin, C., Su, W., Yeh, S. J., Chang, H. & Lin, F. H., 一月 1 2017, 於: Oncotarget. 8, 64, p. 107833-107843 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Angiotensinogen
  • Angiotensin Type 1 Receptor
  • Chronic Renal Insufficiency
  • Confidence Intervals
  • Odds Ratio

• Associations of melatonin receptor gene polymorphisms with Graves' disease

  Lin, J. D., Yang, S. F., Wang, Y. H., Fang, W. F., Lin, Y. C., Liou, B. C., Lin, Y. F., Tang, K. T. & Cheng, C. W., 九月 1 2017, 於: PLoS One. 12, 9, e0185529.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Melatonin Receptors
  • Polymorphism
  • Graves Disease
  • melatonin
  • Genes
  8 引文 斯高帕斯（Scopus）

• Atorvastatin from target screening attenuates endothelial cell tube formation and migration by regulating urokinase receptor-related signaling pathway and F/G actin

  Wei, L., Chen, J. S., Lin, H. T., Wu, C. Z., Zheng, C. M., Chang, Y. C., Chang, L. C. & Lin, Y. F., 二月 1 2017, 於: Journal of the Chinese Medical Association. 80, 2, p. 86-95 10 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Urokinase Plasminogen Activator Receptors
  • Atorvastatin
  • Urokinase-Type Plasminogen Activator
  • Actins
  • Endothelial Cells
  4 引文 斯高帕斯（Scopus）

• Erratum to: Significance of the urokinase-type plasminogen activator and its receptor in the progression of focal segmental glomerulosclerosis in clinical and mouse models

  Chen, J. S., Chang, L. C., Wu, C. Z., Tseng, T. L., Lin, J. A., Lin, Y. F. & Cheng, C. W., 七月 19 2017, 於: Journal of Biomedical Science. 24, 1, 1 p.

  研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

• Far-infrared protects vascular endothelial cells from advanced glycation end products-induced injury via PLZF-mediated autophagy in diabetic mice

  Chen, C. H., Chen, T. H., Wu, M. Y., Chou, T. C., Chen, J. R., Wei, M. J., Lee, S. L., Hong, L. Y., Zheng, C. M., Chiu, I. J., Lin, Y. F., Hsu, C. M. & Hsu, Y. H., 一月 10 2017, 於: Scientific Reports. 7, 40442.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Promyelocytic Leukemia Zinc Finger Protein
  • Advanced Glycation End Products
  • Autophagy
  • Endothelial Cells
  • Vascular Endothelium
  15 引文 斯高帕斯（Scopus）

• Impact of the use of anti-diabetic drugs on survival of diabetic dialysis patients: a 5-year retrospective cohort study in Taiwan

  Hsiao, P. J., Wu, K. L., Chiu, S. H., Chan, J. S., Lin, Y. F., Wu, C. Z., Wu, C. C., Kao, S. Y., Fang, T. C., Lin, S. H. & Chen, J. S., 八月 1 2017, 於: Clinical and Experimental Nephrology. 21, 4, p. 694-704 11 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Taiwan
  • Dialysis
  • Hypoglycemic Agents
  • Cohort Studies
  • Retrospective Studies
  6 引文 斯高帕斯（Scopus）

• Increased long-term risk of major adverse cardiovascular events in patients with carbon monoxide poisoning: A population-based study in Taiwan

  Wong, C. S., Lin, Y. C., Sung, L. C., Chen, T. T., Ma, H. P., Hsu, Y. H., Tsai, S. H., Lin, Y. F. & Wu, M. Y., 四月 1 2017, 於: PLoS One. 12, 4, e0176465.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • carbon monoxide poisoning
  • Carbon Monoxide Poisoning
  • Carbon Monoxide
  • Taiwan
  • cohort studies
  4 引文 斯高帕斯（Scopus）

• Long-term administration of ketamine induces erectile dysfunction by decreasing neuronal nitric oxide synthase on cavernous nerve and increasing corporal smooth muscle cell apoptosis in rats

  Shang, H. S., Wu, Y. N., Liao, C. H., Chiueh, T. S., Lin, Y. F. & Chiang, H. S., 2017, 於: Oncotarget. 8, 43, p. 73670-73683 14 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Nitric Oxide Synthase Type I
  • Ketamine
  • Erectile Dysfunction
  • Smooth Muscle Myocytes
  • Apoptosis
  2 引文 斯高帕斯（Scopus）

• Prevalence and factors associated with food intake difficulties among residents with dementia

  Chang, C. C., Lin, Y. F., Chiu, C. H., Liao, Y. M., Ho, M. H., Lin, Y-K., Chou, K. R. & Liu, M. F., 二月 1 2017, 於: PLoS One. 12, 2, e0171770.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • dementia
  • long term care
  • food intake
  • Dementia
  • Eating
  11 引文 斯高帕斯（Scopus）

• Resveratrol-loaded nanoparticles conjugated with kidney injury molecule-1 as a drug delivery system for potential use in chronic kidney disease

  Lin, Y. F., Lee, Y. H., Hsu, Y. H., Chen, Y. J., Lin, Y. F., Cheng, F. Y. & Chiu, H. W., 十一月 1 2017, 於: Nanomedicine. 12, 22, p. 2741-2756 16 p.

  研究成果: 雜誌貢獻 › 文章 › 同行評審

  • Resveratrol
  • Drug Delivery Systems
  • Nanoparticles
  • Molecules
  • Chronic Renal Insufficiency
  19 引文 斯高帕斯（Scopus）